Skip to main content
Equibles

GEODE CAPITAL MANAGEMENT, LLC

Position in ADIL — Adial Pharmaceuticals, Inc.

CIK 1214717 BOSTON, MA
Back to ADIL Full portfolio

Position in ADIL

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$31,725
-$11,680 QoQ
Shares Held
12,393
-48.9% QoQ
Ownership
0.472%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#5
of 17 holders
Holding Since
Mar 2020
23 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ADIL Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GEODE CAPITAL MANAGEMENT, LLC holds $22,039,427,018 across 520 Biotechnology names. ADIL ranks #487 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 6,017,848 $2,989,245,636
2 REGN
Regeneron Pharmaceuticals, Inc.
 2,625,810 $1,637,297,566
3 ALNY
Alnylam Pharmaceuticals, Inc.
 2,635,840 $793,466,914
4 RVMD
Revolution Medicines, Inc.
 3,942,676 $738,384,360
5 MRNA
Moderna, Inc.
 9,710,335 $680,014,759
6 INCY
Incyte Corp
 4,750,735 $538,543,319
7 RPRX
Royalty Pharma plc
 8,058,048 $451,814,751
8 INSM
INSMED Inc
 4,220,155 $449,952,925

All Filings in ADIL

Export CSV
23 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $31,725 12,393
2026-03-31 $43,405 24,249
2025-12-31 $34,263 155,745
2025-09-30 $57,444 164,127
2025-06-30 $20,654 68,850
2025-03-31 $43,375 68,850
2024-12-31 $62,465 61,847
2024-09-30 $45,466 45,466
2024-06-30 $29,754 25,874
2023-06-30 $28,867 137,464
2023-03-31 $48,112 137,464
2022-12-31 $30,242 137,464
2022-09-30 $48,112 137,464
2022-06-30 $182,091 135,889
2022-03-31 $271,555 135,102
2021-12-31 $349,182 129,327
2021-09-30 $412,170 96,077
2021-06-30 $225,027 88,246
2021-03-31 $188,723 77,985
2020-12-31 $132,574 77,985
2020-09-30 $173,906 77,985
2020-06-30 $108,399 77,985
2020-03-31 $101,380 77,985